# A rare presentation of high-grade serous ovarian carcinoma with ulcerating inguinal lymph node metastasis: a case report

**Authors:** Hassan M Latifah, Ruzanah Almarzugi, Hussam Bitar, Mohammad Alyafi, Abdulmalik Abumohssin, Zuhoor Almansouri, Batool Abdulaziz Kabli, Nusaybah A Shafi, Saeed Baradwan

PMC · DOI: 10.1093/jscr/rjaf317 · 2025-05-21

## TL;DR

A rare case of ovarian cancer spreading to an unusual lymph node is reported, highlighting the need for early detection and genetic testing.

## Contribution

This case report highlights an atypical presentation of high-grade serous ovarian carcinoma with inguinal lymph node metastasis.

## Key findings

- A premenopausal woman presented with an ulcerating inguinal mass, later confirmed as metastatic HGSOC.
- Genetic testing revealed a BRCA1 mutation, guiding adjuvant therapy with Olaparib.
- The case underscores the importance of considering ovarian cancer in atypical lymph node masses.

## Abstract

High-grade serous ovarian carcinoma (HGSOC) typically spreads within the peritoneal cavity, and metastatic spread to extraperitoneal lymph nodes, particularly the inguinal region, is rare. Herein, we present a case of a 47-year-old premenopausal woman who presented with an enlarging, ulcerating right inguinal mass. Imaging revealed a necrotic inguinal mass, with no significant intra-abdominal findings. Surgical excision was performed, and histopathology confirmed metastatic HGSOC. She then underwent neoadjuvant chemotherapy, followed by radiotherapy. She then underwent robotic-surgical staging. Histopathological analysis showed bilateral ovarian involvement with multiple tumor foci. Genetic testing identified a BRCA1 mutation, leading to adjuvant maintenance therapy with Olaparib. This case emphasizes the importance of considering ovarian carcinoma in the differential diagnosis of unusual inguinal lymph node masses, even without a visible ovarian mass. Early detection, genetic testing, and a multidisciplinary approach are essential for optimizing patient outcomes in advanced HGSOC with atypical metastasis.

## Linked entities

- **Genes:** BRCA1 (BRCA1 DNA repair associated) [NCBI Gene 672]
- **Chemicals:** Olaparib (PubChem CID 23725625)

## Full-text entities

- **Genes:** BRCA1 (BRCA1 DNA repair associated) [NCBI Gene 672] {aka BRCAI, BRCC1, BROVCA1, FANCS, IRIS, PNCA4}
- **Diseases:** tumor (MESH:D009369), lymph node (MESH:D000072717), ovarian mass (MESH:D010049), metastasis (MESH:D009362), HGSOC (MESH:D010051), necrotic inguinal mass (MESH:C536030)
- **Chemicals:** Olaparib (MESH:C531550)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12093310/full.md

---
Source: https://tomesphere.com/paper/PMC12093310